Dr. Sushama R. Chaphalkar

PhD in Microbiology

Biotechnology, Microbiology

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.

Dr. Chaphalkar is passionate about sustainable development through Biotechnology and brought about significant agrarian development in parts of rural Maharashtra, through her 11-year-long project titled “Biovillage,” which involved need-based research as well as training of the rural population, especially farmers. When she is not working or mentoring students, she finds joy in avid reading, music, gardening, culinary adventures, and exploring new destinations through travel.

See less

Articles from Sushama R.

Can adding RNA sequencing to germline genetic testing improve accuracy and clinical sensitivity over time compared to DNA sequencing alone?

Concurrent sequencing of DNA and RNA to detect the predisposition to hereditary cancer.

8 Nov 2023

Study shows depression increases disability risk in rheumatoid arthritis sufferers

The interactions between rheumatoid arthritis (RA) and major depressive disorder (MDD).

7 Nov 2023

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Dutch study finds SSRIs significantly alleviate post-COVID syndrome symptoms, offering promising treatment avenues and shedding light on neurobiological mechanisms at play.

5 Nov 2023

Study links heavy mobile phone use to lower sperm count

Swiss study finds higher mobile phone use linked to lower sperm count and concentration in young men, raising concerns about RF-EMF exposure's impact on male reproductive health. Despite limitations, the research suggests a potential risk to fertility with increasing phone usage.

2 Nov 2023

Brain's pitch perfect: New study tunes into Mandarin tone control

Researchers reveal that local neural populations in the brain's bilateral laryngeal motor cortex are key in controlling the pitch dynamics in Mandarin lexical tones, overturning the idea of single-tone category encoding. Direct stimulation of these areas alters pitch, advancing our understanding of speech production and potential treatments for speech disorders.

2 Nov 2023

Research reveals both protective and harmful gut microbiota associated with sleep apnea risk

The causal relationship between gut microbiota, associated metabolites, and obstructive sleep apnea (OSA).

30 Oct 2023

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

Canadian researchers develop a cell-free DNA-based multimodal assay for early cancer detection in patients with Li-Fraumeni Syndrome, a high-cancer-risk condition. The assay outperforms conventional methods, promising more sensitive and less invasive cancer surveillance.

29 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

The intricate interplay of stress, quality of life, and gut microbiota in newly diagnosed breast cancer patients

Researchers investigated the relationship between quality of life (QOL), stress, and gut microbiota in patients newly diagnosed with breast cancer.